US Broker Ratings

Abivax SA (ABVX) Stock Analysis: Investors Eye 28.97% Upside as Biotech Firm Advances in Inflammatory Disease Treatments

Abivax SA (ABVX), a French biotechnology company, has captured the attention of investors with its focus on developing therapeutics for chronic inflammatory diseases. With a current..

Upstream Bio, Inc. (UPB) Stock Analysis: Assessing the 172% Potential Upside

In the realm of biotechnology, where innovation meets opportunity, Upstream Bio, Inc. (NASDAQ: UPB) is carving its niche with a focus on inflammatory diseases. Operating in..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 90% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS) stands as a noteworthy contender in the healthcare sector, with a particular focus on developing medical devices aimed at pain relief and..

Septerna, Inc. (SEPN) Stock Analysis: Biotechnology Trailblazer with 20.35% Potential Upside

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to drug discovery and development. Specializing..

Valneva SE (VALN) Stock Analysis: Exploring a Potential 17% Upside in the Vaccine Innovator

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in vaccines for infectious diseases, presents an intriguing opportunity for investors, especially those keen on the healthcare..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 160% Potential Upside in Precision Medicine

Relay Therapeutics, Inc. (NASDAQ: RLAY) is making waves in the biotechnology sector with its innovative approach to drug discovery, particularly in targeted oncology and genetic disease..

Sionna Therapeutics, Inc. (SION): Investor Outlook with a 29.69% Potential Upside

Sionna Therapeutics, Inc. (NASDAQ: SION), a rising star in the biotechnology sector, is catching the eye of investors with its promising potential upside of 29.69%. This..

Kamada Ltd. (KMDA) Stock Analysis: Strong Buy Ratings and a Potential 105% Upside in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), a notable player in the healthcare sector with a focus on plasma-derived protein therapeutics, is garnering strong attention from investors. Based in..

Neuropace, Inc. (NPCE) Stock Analysis: Eyeing a 60% Upside Potential with Strong Buy Ratings

Neuropace, Inc. (NASDAQ: NPCE), a notable player in the medical devices sector, is capturing investor attention with its innovative solutions in the healthcare industry. The company..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Uncovering a Potential 225% Upside in Biotechnology

Investors eyeing the biotechnology sector might find MeiraGTx Holdings plc (NASDAQ: MGTX) an intriguing prospect, particularly given its potential upside of 225.40% based on analyst ratings...

Arvinas, Inc. (ARVN) Stock Analysis: Unpacking a 92.91% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may want to pay close attention to Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage company making waves with its..

Delcath Systems, Inc. (DCTH) Stock Analysis: Healthcare Innovator with a 128% Upside Potential

Delcath Systems, Inc. (NASDAQ: DCTH), a pioneering force in the healthcare sector, is capturing investor attention with its focus on innovative treatments for liver cancers. Headquartered..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a 20% Upside in the Biotech Sector

Prothena Corporation plc (NASDAQ: PRTA), a dynamic player in the biotechnology sector, offers a compelling case for investors seeking exposure to innovative healthcare solutions. Based in..

Mind Medicine (MNMD) Stock Analysis: 95% Potential Upside Draws Investor Attention

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating brain health disorders...

Inventiva S.A. (IVA) Stock Analysis: Unpacking the 122.69% Potential Upside

Investors with an eye on the biotechnology sector may find Inventiva S.A. – American Depositary Shares (IVA) an intriguing prospect. With a reported potential upside of..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring an 88.83% Potential Upside in Pediatric Medical Devices

OrthoPediatrics Corp. (NASDAQ: KIDS), a specialized player in the healthcare sector, focuses on the niche yet crucial segment of pediatric orthopedic medical devices. Headquartered in Warsaw,..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Insights into a Biotech with 42.77% Potential Upside

Maze Therapeutics, Inc. (MAZE) is a clinical-stage biopharmaceutical company operating in the dynamic biotechnology sector. With a market capitalization of $1.16 billion, this South San Francisco-based..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Biotech Firm with 59% Upside Potential

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) presents a compelling narrative for investors within the biotechnology sector. This clinical-stage biopharmaceutical company, headquartered in South San Francisco, California, focuses..

Theravance Biopharma, Inc. (TBPH) Investor Outlook: Exploring a Potential 42% Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a standout player in the biotechnology sector, is piquing investor interest with its compelling growth narrative and promising market outlook. Headquartered..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a 56% Potential Upside for Investors

AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology company headquartered in Vancouver, is capturing the attention of investors with its promising growth metrics and substantial potential..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds